News
Stories and articles featuring PCI, our partners, and Penn-affiliated spinout companies
Penn Engineering’s Professors Discuss Innovations Over Tea
Their “brewing” collaboration recently led to the development of a novel chip that uses light for vector-matrix multiplication.
Penn Medicine Researchers Study New Treatment Options for Brain Cancer Patients
A team of Penn researchers are exploring whether MRIs that measure the "temperature" of tumors could enhance treatment for glioblastoma, a deadly brain cancer.
Philadelphia Business Journal’s Innovation Sector Celebrates iECURE as PHL Inno’s 2024 Fire Awards Honoree
The Fire Awards aim to celebrate the most promising businesses and individuals driving success and innovation locally in Greater Philadelphia.
President’s Sustainability Prize Winner Shinkei Systems Aims to Upend the Fish-Harvesting Industry
The 2022 President’s Sustainability Prize winner Shinkei Systems was recognized in a recent article by Tech Crunch for its role in changing the seafood industry.
EpiVario Awarded NIH Grant to Advance Research in Treatments for Cocaine Use Disorder
EpiVario is developing neuroepigenetic modulators to treat memory-related addiction and psychiatric disorders.
Ultragenyx Announces FDA Acceptance and Priority Review of the Biologics License Application (BLA) for Sanfilippo Gene Therapy Based on Penn Technology
The drug relies on licensed foundational gene therapy technology created in the laboratory of Dr. James Wilson, MD, PhD.
Interius BioTherapeutics Receives Clearance to Begin Phase 1 Clinical Trial for Its First-in-Class In Vivo CAR Therapeutic for B Cell Malignancies
Interius intends to begin patient enrollment for the trial in the fourth quarter of 2024.
Development of RNA Therapeutics Targets Neurological Diseases
The collaboration combines Ascidian's RNA exon editing technology with Roche's expertise in CNS delivery to create novel treatments for hard-to-treat neurological conditions.
Cabaletta’s Early Data Shows Potential for Treating Autoimmune Diseases
The company reported positive results in the first two patients who received its new CAR T therapy, CABA-201, which aims to treat the autoimmune diseases lupus and myositis.
Study Highlights Growth and Impact of Greater Philadelphia’s Booming Cell and Gene Therapy Industry
The Greater Philadelphia Chamber of Commerce published a comprehensive snapshot of the region’s cell and gene therapy sector.